Healthcare
Kneat.com, Inc.(KSIOF)
Live Price
Offline$4.60
+0.00% today
1Y Change
+3.51%
Window
Jun 25, 2025 โ Jun 16, 2026
- Market Cap
- $430.00M
- Revenue Growth
- +29.2%
- EPS Growth
- +72.6%
- Dividend Yield
- 0.0%
Coverage: 245 bars ยท Jun 25, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Kneat.com, Inc. (KSIOF) is a Healthcare stock with a market cap of $430.00M and listed on OTC. The stock last traded around $4.60 and up 3.5% across the available one-year price window (Jun 25, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +29.2%, EPS growth of +72.6%, a dividend yield of 0.0%. What stands out right now is revenue +29.2%, EPS +72.6%, free cash flow +218.6% with operating margin -13.4% and ROIC -9.0%. Valuation sits in the middle of the pack at price/sales 6.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines KSIOF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+29.2% vs +7.6% peer median
Operating Margin
Below sector median
-13.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 6, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +29.2% and EPS at +72.6%, with operating margin around -13.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -6.0% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 6, 2026 | โ | -0.2% | +8.4% | +13.6% |
2026 Feb 25, 2026 | -53.9% | -1.4% | -8.9% | -15.9% |
2025 Nov 12, 2025 | +88.5% | -14.2% | -17.4% | -7.2% |
Benchmark Edge
KSIOF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
KSIOF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
KSIOF Max Drawdown
-47.72%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for KSIOF and SPY.
Company Overview
Kneat.com, Inc.
Other OTC
kneat.com, inc. designs, develops, and supplies software for data and document management within regulated environments in the United States, Ireland, Canada, and internationally. The company offers Kneat Gx platform, a configurable commercial off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in process, computer system, cleaning, analytical instrument, method, utility and facility, equipment, and cold chain validation, as well commissioning and qualification, and electronic logbook management. The company also provides software-related services, including training, installation, upgradation, consulting, and maintenance, as well as process mapping, project management, and other services. kneat.com, inc. is headquartered in Limerick, Ireland.
- Leadership
- Edmund Ryan
- IPO Date
- Jul 1, 2014
- Employees
- 297
- Street Address
- Castletroy Business Park
- Mailing
- Limerick, V94 KW28
- Region
- Limerick, IE
- Reporting Currency
- USD
- Investor Line
- 353 6 120 3826
- Last Updated
- May 1, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 24.6
- Price/Sales
- 6.9
- Price/Book
- 6.7
Growth
- Revenue
- +29.2%
- EPS
- +72.6%
- Free Cash Flow
- +218.6%
Profitability
- Gross Margin
- 64.3%
- Operating Margin
- -13.4%
- Net Margin
- -3.7%
- ROE
- -3.6%
- ROIC
- -9.0%
Balance Sheet
- Debt/Equity
- 0.54
- Current Ratio
- 1.82
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.